-
Novel URAT1 Inhibitor Successful in Proof-of-Concept Trial & More Late-Breaking Abstracts
Robert Keenan, MD, MPH, MBA, presented one of five late-breaking abstracts on the final day of ACR Convergence 2023. He discussed research showing the efficacy of AR882 in gout compared to allopurinol. Other cutting-edge science in the session related to immunosuppressant use in long-term IgG4-RD,…
-
Rare Inborn Errors of Immunity Can Inform More Common Autoimmune Diseases
Experts in the field including Daniel Kastner, MD, PhD, discussed their work on extrapolating insights on the mechanisms of specific inborn errors of immunity to more common rheumatologic diseases. Dr. Kastner gave an overview of the landscape of inborn errors of immunity, highlighting immunodeficiencies, autoimmunity,…
-
Dermatologist Shares Efficacy of Monoclonal Antibody for Treatment of Lupus Rashes
Anifrolumab gained U.S. Food and Drug Administration approval for use in systemic lupus in 2021, and the drug has had positive results among adults and adolescents with recalcitrant cutaneous lupus erythematosus, too. Katharina S. Shaw, MD, reviewed commonly observed rashes in rheumatologic patients and how…
-
Healthcare Providers Discuss Compassion for Self and Others — How to Practice It and How to Teach It
Self-compassion is a way to protect against burnout for healthcare professionals. Vaneet Sandhu, MD, MS, RhMSUS, explained how compassion fatigue and fear of compassion are related, and how to incorporate compassion curriculum into healthcare training.
-
Panelists Discuss How and When to Safely Use Steroids in RA
Rheumatologists may be tempted to use steroids in patients with very active disease as they wait for a disease-modifying antirheumatic drug to take effect. But Vivian Bykerk, MD, cautioned in a Meet the Panel session that this strategy can be counterproductive.
-
Experts Review Nervous System Manifestations in Sjögren’s Syndrome
Brent P. Goodman, MD, Arun D. Varadhachary, MD, PhD, and Julius Birnbaum, MD, discussed the challenging complications of the nervous system that can present in patients with Sjögren’s syndrome, as well as practical strategies for the management of them.
-
New ACR Guidelines for Screening, Monitoring, and Treatment of SARD-ILD in Focus
Panelists provided insight into the forthcoming ACR guidelines on systemic autoimmune rheumatic disease associated with interstitial lung disease. Sindhu R. Johnson, MD, PhD, discussed some of the 50 recommendations in the guideline.
-
ACR/EULAR Develop New APS Classification Criteria
Doruk Erkan, MD, MPH, and Jason S. Knight, MD, PhD, explained the antiphospholipid syndrome classification criteria developed by the ACR and EULAR, including clinical features, risk stratification of macrovascular events, re-defined pregnancy morbidity definitions, and more.
-
EULAR Update Helps Refine Diagnosis and Treatment of Lupus
An expert panel on lupus treatment highlighted the 2023 update to the EULAR recommendations for the management of systemic lupus erythematosus. Maria Dall’Era, MD, Richard Furie, MD, and Marta Mosca, MD, PhD, led the discussion using patient cases to illustrate how to manage the challenges…